𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases

✍ Scribed by Christiane J. Bruns; Wenbiao Liu; Darren W. Davis; Raymond M. Shaheen; David J. McConkey; Michael R. Wilson; Corazon D. Bucana; Daniel J. Hicklin; Lee M. Ellis


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
531 KB
Volume
89
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Combined analysis of p53 and vascular en
✍ Soon-Myoung Kang; Kiyoshi Maeda; Naoyoshi Onoda; Yong-Suk Chung; Bunzo Nakata; Y πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 326 KB πŸ‘ 2 views

Recent studies have demonstrated that the p53 tumor suppressor gene plays an important role in controlling tumor angiogenesis. We examined the expression of p53 and vascular endothelial growth factor (VEGF), a well-characterized angiogenic inducer, together with microvessel density to investigate th

KDR/Flk-1 is a major regulator of vascul
✍ Hitoshi Yoshiji; Shigeki Kuriyama; Daniel J. Hicklin; James Huber; Junichi Yoshi πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 375 KB πŸ‘ 1 views

Vascular endothelial growth factor (VEGF), which is one of the most potent angiogenic factors, has been shown to play a pivotal role in tumor angiogenesis, including hepatocellular carcinoma (HCC). The effects of VEGF are mediated mainly through two distinct receptors, flt-1 and KDR/ Flk-1. It has b